Compare ALLO & RSVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALLO | RSVR |
|---|---|---|
| Founded | 2017 | 2007 |
| Country | United States | United States |
| Employees | N/A | 100 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 707.6M | 673.7M |
| IPO Year | 2018 | N/A |
| Metric | ALLO | RSVR |
|---|---|---|
| Price | $2.07 | $10.20 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 1 |
| Target Price | $8.35 | ★ $11.50 |
| AVG Volume (30 Days) | ★ 9.0M | 53.9K |
| Earning Date | 05-07-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.09 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $10.95 |
| Revenue Next Year | $142,416.42 | $4.16 |
| P/E Ratio | ★ N/A | $77.14 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.99 | $7.07 |
| 52 Week High | $4.46 | $13.39 |
| Indicator | ALLO | RSVR |
|---|---|---|
| Relative Strength Index (RSI) | 49.96 | 49.76 |
| Support Level | $1.85 | $10.06 |
| Resistance Level | $2.36 | $10.27 |
| Average True Range (ATR) | 0.13 | 0.23 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 60.00 | 28.57 |
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
Reservoir Media Inc is an independent music company. The company operates a music publishing business, a recorded music business, a management business, and a rights management entity in the Middle East. The company's segments include Music Publishing and Recorded Music. It generates the maximum of its revenue from the U.S. Music Publishing segment engaged in the acquisition of interests in music catalogs to earn royalties and signing songwriters to agreements of future delivery of songs. The Recorded Music segment involve the acquisition of sound recording catalogs and the discovery and development of recording artists and the marketing, distribution, sale and licensing of the music catalog.